Disc Medicine faces a regulatory setback as the FDA issued a CRL for bitopertin, citing insufficient clinical benefit evidence despite clear biomarker reduction. The upcoming Phase 3 APOLLO trial, ...
Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Adam Feuerstein is a senior ...
Label maker Multi-Color and some of its lenders are gearing up for a showdown on Tuesday over the company’s decision to file for bankruptcy in New Jersey, as those creditors claim bank accounts opened ...
Eight years after the arrival of the Sonos Amp, which supported four speakers for high-end streaming audio around your house, the brand's leveled things up with new hardware for bigger homes. The Amp ...
Sonos has unveiled its first new product of 2026, the Amp Multi. This amplifier is a niche option for the owners of very large or complicated spaces, and it's being billed as professional grade option ...
The first new Sonos hardware product in over a year is the Sonos Amp Multi, a professional-grade multi-channel streaming amplifier designed specifically for large-scale residential audio installations ...
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Sonos (Nasdaq: SONO) today announced Sonos Amp Multi, a one-of-a-kind multi-channel streaming amplifier designed to make complex residential audio installations ...
Golden Disc has opened the year with its 40th ceremony! The 40th Golden Disc Awards was held at Taipei Dome on January 10, awarding the best albums and songs of the past year. 10 Best Albums and 10 ...
Disc Medicine is well-capitalized, with over $800M in cash, ensuring operational runway through 2029 regardless of bitopertin's launch success. Bitopertin’s NDA is submitted, aiming for accelerated ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results